Survivorship and Improving Quality of Life in Men with Prostate Cancer
Liam Bourke(Sheffield Hallam University), David F. Penson(Geriatric Research Education and Clinical Center), Lorelei A. Mucci(American Cancer Society), Stephen A. Boorjian(Mayo Clinic), Laurence Klotz(University of Toronto), Matthew J. Resnick(Vanderbilt University Medical Center), Ted A. Skolarus(Chicago Department of Public Health), Alberto Briganti(Vita-Salute San Raffaele University), Derek J. Rosario(Royal Hallamshire Hospital)
Cited by 122
Related Papers
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
|The Lancet Public Health|2020|2.3k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
The Epidemiology of Prostate Cancer
|Cold Spring Harbor Perspectives in Medicine|2018|761
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688